(Q44918007)
Statements
A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent (English)
Jos H Beijnen
Jan H M Schellens
Jeany M Rademaker-Lakhai
scientific article
No description defined